Thomas, Sarah E. http://orcid.org/0000-0002-1343-353X
Barenbrug, Liana
Hannink, Gerjon
Seyger, Marieke M. B.
de Jong, Elke M. G. J.
van den Reek, Juul M. P. A.
Article History
Accepted: 25 March 2024
First Online: 17 April 2024
Declarations
:
: No external funding was received for the preparation of this article.
: Sarah E. Thomas carries out clinical trials for Janssen and Novartis and received speaking fees from Eli Lilly and AbbVie. All funding is not personal but goes to the independent Research Fund of the Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, the Netherlands. Liana Barenbrug and Gerjon Hannink have no conflicts of interest that are directly relevant to the content of this article. Marieke M.B. Seyger received grants from/was involved in clinical trials from AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Leo Pharma and Pfizer. She served as a consultant for AbbVie, Eli Lilly, Janssen, Leo Pharma, Novartis, Pfizer and UCB; fees were paid directly to the Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, the Netherlands. Elke M.G.J. de Jong has received research grants for the independent research fund of the Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, the Netherlands, from AbbVie, BMS, Janssen Pharmaceutica, Leo Pharma, Novartis and UCB for research on psoriasis and has acted as a consultant and/or paid speaker for and/or participated in research sponsored by companies that manufacture drugs used for the treatment of psoriasis or eczema including AbbVie, Amgen, Almirall, Boehringer Ingelheim, Celgene, Galapagos, Janssen Pharmaceutica, Leo Pharma, Lilly, Novartis, Sanofi and UCB. All funding is not personal but goes directly to the Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, the Netherlands. Juul M.P.A. van den Reek carried out clinical trials for AbbVie, Celgene, Almirall and Janssen and has received speaking fees/attended advisory boards from AbbVie, Janssen, BMS, Almirall, LEO Pharma, Novartis, UCB and Eli Lilly and reimbursement for attending or chairing a symposium from Janssen, Pfizer, Celgene and AbbVie. All funding is not personal but goes to the independent research fund of the Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, the Netherlands.
: Not applicable.
: Not applicable.
: Not applicable.
: The underlying datasets and scripts are available for review upon request.
: Not applicable.
: All authors contributed to the study conception and design. The literature search, data collection and analysis were performed by Sarah Thomas, Liana Barenbrug and Gerjon Hannink. The first draft of the manuscript was written by Sarah Thomas and Liana Barenbrug. Gerjon Hannink, Marieke Seyger, Elke de Jong, and Juul van den Reek critically revised the manuscript. All authors read and approved the final manuscript.